首批！合胞病毒RSV“预防针”适合谁？News! Who is advised to receive Nirsevimab?

文章预览

The long-acting monoclonal antibody Beyfortus® (Nirsevimab Injection) has been approved in China, commonly known as “RSV Preventive Injection”, can be used to prevent lower respiratory tract (LRTD) infections caused by respiratory syncytial virus (RSV) in newborns and infants. 国内已获批的长效单克隆抗体乐唯初®（尼塞韦单抗注射液/Nirsevimab），俗称“RSV合胞病毒预防针”,  主要用于预防新生儿和婴儿由呼吸道合胞病毒（RSV）引起的下呼吸道（LRTD）感染。 点击视频观看莱佛士儿科主任Dr Cecille Brion科普 Q：What is RSV? 什么是 RSV合胞病毒？ RSV is a common and highly contagious seasonal virus. lt is the most common cause of LRTD in children and infants, including bronchiolitis and pneumonia，and is also a leading cause of hospitalisation in all infants. Bronchiolitis (swelling of the small airway passages in the lungs), that often leads to an emergency department or physician office visit. Premat ………………………………